Pretreatment Hematocrit Is Superior to Hemoglobin as a Prognostic Factor for Triple Negative Breast Cancer

首页 > 成果 > 详情

认领

导出

下载 Link by DOI

反馈

作者信息关键词期刊信息基础信息归属信息摘要

成果类型：

期刊论文

作者：

Chen, Bo;Dai, Danian;Tang, Hailin;Ai, Xiaohong;Chen, Xi;...

通讯作者：

Xie, Xiaoming

作者机构：

[Dai, Danian; Tang, Hailin; Xie, Xiaoming; Chen, Bo] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept Breast Oncol,Canc Ctr, Guangzhou, Guangdong, Peoples R China.

[Ai, Xiaohong] Univ South China, Affiliated Hosp 1, Dept Radiotherapy, Hengyang, Hunan, Peoples R China.

[Chen, Xi] Univ South China, Coll Med, Dept Anat, Hengyang, Hunan, Peoples R China.

[Li, Zhiyan; Zhang, Xiaoyan] Univ South China, Affiliated Nanhua Hosp, Dept Gastroenterol, Hengyang, Hunan, Peoples R China.

通讯机构：

[Xie, Xiaoming] S

Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept Breast Oncol,Canc Ctr, Guangzhou, Guangdong, Peoples R China.

语种：

英文

关键词：

Breast cancer;Cancer treatment;Lung and intrathoracic tumors;Anemia;Prognosis;Renal cancer;Hematocrit;Multivariate analysis

期刊：

PLOS ONE

ISSN：

1932-6203

年：

2016

卷：

期：

页码：

e0165133

DOI：

10.1371/journal.pone.0165133

基金类别：

National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81472575, 81272514, 81372133, 81472469]; Science and Technology Planning Projects of Guangdong and Guangzhou [2014J4100169, 20136060300009, 20156020211002, 20156090901050, 2014A020212079]

机构署名：

本校为其他机构

院系归属：

医学院

摘要：

Background: Anemia usually refers to low hemoglobin (Hb) levels. Previous studies indicated that anemia negatively influence the survival in various cancers. Hematocrit (HCT) is the volume percentage of red blood cells in blood, which could indicate anemia in both individuals and populations. This study compared the value of HCT with that of Hb for predicting outcomes of patients who underwent treatment for triple negative breast cancer (TNBC). Methods: A retrospective study of 293 triple negative breast cancer patients, accepting treatment fro...

反馈

产权有误：本人成果被他人认领

数据有误：数据基本信息有误

归属有误：成果的院系归属、机构署名归属有误

其他原因：

验证码：

看不清楚，换一个

确定

取消

成果认领

标题：

用户	作者	通讯作者	--
	请选择	请选择	--

确定

取消

Pretreatment Hematocrit Is Superior to Hemoglobin as a Prognostic Factor for Triple Negative Breast Cancer

反馈

成果认领

提示

该栏目需要登录且有访问权限才可以访问